Obstructive sleep apnea (OSA), the most common type of sleep apnea, tends to be most common in people who are heavier, have larger necks, and are older, among other risk factors.

But patients would rather treat their sleep apnea with tirzepatide (Zepbound), a GLP-1 weight-loss drug, researchers found. "The results highlight a need for real-world comparative effectiveness ...

From home sleep tests to AI-assisted care, discover how today’s OSA treatment goes far beyond CPAP machines.

According to a new study, presented at the American College of Cardiology (ACC) Care of the Athletic Heart 2025 conference, sleep apnea may be more prevalent in younger female athletes than ...

Today marks a transformative moment in the 35-year history of the American Sleep Apnea Association (ASAA). The organization proudly rebrands as the Wellness, Sleep & Circadian Network (WSCN), a ...

By Dennis Thompson HealthDay ReporterMONDAY, June 9, 2025 (HealthDay News) — A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a ...

Snoring can often be a sign of obstructive sleep apnea, the most common sleep-related breathing disorder estimated to impact over 25 million U.S. adults.

However, Dr Akshay Budhraja, HOD, Respiratory and Sleep Medicine, Aakash Healthcare, Delhi, says, “Mouth taping is undertaken by several adults who face issues with sleep.

Mosanna Therapeutics, a biotech company rethinking treatment of obstructive sleep apnea (OSA), today announced the close of $80 million in Series A funding. The company is developing an easy-to ...

Copying a baby's facial expressions can help parents bond with child 18 iconic airlines that vanished from the skies Breathe easy: Sleep apnea is dangerous but treatments are available 12 ...

Sleep disorders may lead to structural brain changes, cognitive decline, and neurological disease. Here’s what science says about the risk.

How does it work? Published: June 12, 2025 2:47am EDT Sleep disorders Health weight-loss drugs Sleep apnea Mounjaro Tirzepatide Health in the news Register now ...